MARK2 and breast cancer: Importantly, we were also able to confirm, by RT-PCR, the aberrant AS regulation of PACSIN2, DIAPH1, MARK3, ADD3, MAP3K7, and MARK2 in RNA extracts from two human tumor breast cancer samples tissues and two non-pathological tissues (Figure S4).